Applied DNA Sciences (APDN) Tops Q2 EPS by 25c

Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of $0.05, $0.25 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $4.41 million versus the consensus estimate of $4.11 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13